Latest Influenza research Stories
Nanotherapeuticsâ€™ GelVacâ„¢ Nasal Dry-Powder H5N1 Influenza Vaccine Shown to Be Safe in Early Stage Clinical Trial
A novel dry-powder formulation nasal flu vaccine for the H5N1 strain, GelVacâ„¢ Nasal Dry-Powder H5N1 Influenza, was proven to be safe in an early stage clinical trial.
Word of the Day
The word 'pawl' probably comes from a Latin word meaning 'stake'.